Elisabetta Ferretti

Pubblicazioni

Titolo Pubblicato in Anno
Targeting FGFRs by pemigatinib induces G1 phase cell cycle arrest, cellular stress and upregulation of tumor suppressor microRNAs JOURNAL OF TRANSLATIONAL MEDICINE 2023
Network analysis identifies circulating miR-155 as predictive biomarker of type 2 diabetes mellitus development in obese patients: a pilot study SCIENTIFIC REPORTS 2023
Circulating cell-free DNA (cfDNA) in patients with medullary thyroid carcinoma is characterized by specific fragmentation and methylation changes with diagnostic value BIOMARKER RESEARCH 2023
mTORC1/ERK1/2 Interplay Regulates Protein Synthesis and Survival in Acute Myeloid Leukemia Cell Lines BIOLOGY 2023
The endocrine disruptor cadmium modulates the androgen-estrogen receptors ratio and induces inflammatory cytokines in luminal (A) cell models of breast cancer ENDOCRINE 2023
Hypocalcemia in combination with hyperphosphatemia impairs muscle cell differentiation in vitro JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION 2023
Environmental contaminants acting as endocrine disruptors modulate atherogenic processes: New risk factors for cardiovascular diseases in women? BIOMOLECULES 2022
HOXD8 hypermethylation as a fully sensitive and specific biomarker for biliary tract cancer detectable in tissue and bile samples BRITISH JOURNAL OF CANCER 2022
MicroRNA loaded edible nanoparticles: an emerging personalized therapeutic approach for the treatment of obesity and metabolic disorders THERANOSTICS 2022
Low molecular weight heparin -induced miRNA changes in peripheral blood mononuclear cells in pregnancies with unexplained recurrent pregnancy loss JOURNAL OF REPRODUCTIVE IMMUNOLOGY 2022
Identification and Validation of miR-222-3p and miR-409-3p as Plasma Biomarkers in Gestational Diabetes Mellitus Sharing Validated Target Genes Involved in Metabolic Homeostasis INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES 2022
Circulating microRNAs as clinically useful biomarkers for Type 2 Diabetes Mellitus: miRNomics from bench to bedside TRANSLATIONAL RESEARCH 2022
Cell-Target-Specific Anti-Inflammatory Effect of Empagliflozin: In Vitro Evidence in Human Cardiomyocytes FRONTIERS IN MOLECULAR BIOSCIENCES 2022
{MEDB}-09. Unraveling the role of unfolded protein response in medulloblastoma cancer stem cells NEURO-ONCOLOGY 2022
MiR-1248: a new prognostic biomarker able to identify supratentorial hemispheric pediatric low-grade gliomas patients associated with progression BIOMARKER RESEARCH 2022
miRNAs and isomiRs: serum-based biomarkers for the development of intellectual disability and autism spectrum disorder in tuberous sclerosis complex BIOMEDICINES 2022
A novel microRNA signature for the detection of melanoma by liquid biopsy JOURNAL OF TRANSLATIONAL MEDICINE 2022
DNA damage response and repair (DDR) gene mutations as an alternative mechanism to generate high TMB in never smoker NSCLC patients ANNALS OF ONCOLOGY 2022
Reduced miR-184-3p expression protects pancreatic β-cells from lipotoxic and proinflammatory apoptosis in type 2 diabetes via CRTC1 upregulation CELL DEATH DISCOVERY 2022
Rethinking the Management of Optic Pathway Gliomas: A Single Center Experience FRONTIERS IN SURGERY 2022

Progetti di Ricerca

Gruppi di ricerca

Integrated Diagnostics in Prostate Cancer supported by Computational Algorithms (AI and network analysis)
Gestational diabetes; Risk Factors; Outcomes

© Università degli Studi di Roma "La Sapienza" - Piazzale Aldo Moro 5, 00185 Roma